Literature DB >> 14625042

Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease.

J Tian1, J Shi, K Bailey, D M A Mann.   

Abstract

Cerebral amyloid angiopathy (CAA) is an important, though still relatively neglected, aspect of the pathology of Alzheimer's disease (AD), and both the source of amyloid beta protein (Abeta) in CAA, and its relationship to senile plaque (SP) Abeta, remain unclear. We have investigated the relationship between Abeta deposition in SP and CAA in four regions of brain from 69 patients with AD in order to gain insight into the pathogenetic mechanism(s) underlying these pathologies. CAA was present to some degree in all 69 patients, with the occipital cortex being affected more often and more severely than frontal, temporal and parietal cortices. By definition, SPs were present in all brain areas in all 69 patients, with greater uniformity of distribution than CAA, though the occipital cortex was less severely affected than the other brain regions. There was no significant (positive) correlation between CAA rating and that of SP for any one cortical region, but on combining data from all four regions there was a significant inverse correlation (P=0.037) between CAA and SP ratings. Such data suggest that the cellular sources and mechanisms leading to Abeta deposition as SP or CAA are likely to differ and may proceed independently of each other.

Entities:  

Mesh:

Year:  2003        PMID: 14625042     DOI: 10.1016/j.neulet.2003.08.048

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

Authors:  E Kövari; F R Herrmann; P R Hof; C Bouras
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

2.  Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy.

Authors:  Oliver J Standring; Jacob Friedberg; Yorghos Tripodis; Alicia S Chua; Jonathan D Cherry; Victor E Alvarez; Bertrand R Huber; Weiming Xia; Jesse Mez; Michael L Alosco; Raymond Nicks; Ian Mahar; Morgan J Pothast; Hannah M Gardner; Gaoyuan Meng; Joseph N Palmisano; Brett M Martin; Brigid Dwyer; Neil W Kowall; Robert C Cantu; Lee E Goldstein; Douglas I Katz; Robert A Stern; Ann C McKee; Thor D Stein
Journal:  Acta Neuropathol       Date:  2019-06-10       Impact factor: 17.088

3.  beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice.

Authors:  Michael Willem; Ilse Dewachter; Neil Smyth; Tom Van Dooren; Peter Borghgraef; Christian Haass; Fred Van Leuven
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

4.  Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer's disease.

Authors:  Nadine El Tannir El Tayara; Benoît Delatour; Andreas Volk; Marc Dhenain
Journal:  MAGMA       Date:  2010-02       Impact factor: 2.310

5.  The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.

Authors:  Shino Magaki; Zhaoyi Tang; Spencer Tung; Christopher K Williams; Darrick Lo; William H Yong; Negar Khanlou; Harry V Vinters
Journal:  Neurobiol Aging       Date:  2018-06-11       Impact factor: 4.673

6.  Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.

Authors:  Ping He; Zhenyu Zhong; Kristina Lindholm; Lilian Berning; Wendy Lee; Cynthia Lemere; Matthias Staufenbiel; Rena Li; Yong Shen
Journal:  J Cell Biol       Date:  2007-08-27       Impact factor: 10.539

7.  Modelling neuroinflammatory phenotypes in vivo.

Authors:  Marion S Buckwalter; Tony Wyss-Coray
Journal:  J Neuroinflammation       Date:  2004-07-01       Impact factor: 8.322

Review 8.  Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).

Authors:  Mubashir Hassan; Qamar Abbas; Sung-Yum Seo; Saba Shahzadi; Hany Al Ashwal; Nazar Zaki; Zeeshan Iqbal; Ahmed A Moustafa
Journal:  Mol Med Rep       Date:  2018-05-22       Impact factor: 2.952

Review 9.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

10.  Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.

Authors:  Dixon Yang; Arjun V Masurkar
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jan-Mar 01       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.